Alubri Launches Medically-Backed Intimate Care Line, Targeting Menopause

RALEIGH, N.C. – February 24, 2026 – A new brand named Alubri launched today, entering the rapidly expanding women's wellness market with a clear mission: to fuse clinical science with accessible intimate care. Co-founded by a board-certified OB/GYN, Dr. Nicole Kerner, the company aims to address what it calls a significant unmet need in women's health, particularly for those experiencing the vaginal changes associated with perimenopause and menopause.

With a product line developed under medical oversight and an ethos of creating a supportive “sisterhood,” Alubri is positioning itself at the intersection of medical credibility and modern consumer wellness. The brand seeks to move the conversation from stigmatized “feminine hygiene” to a more holistic and respected pillar of whole-body health.

"Our vision for Alubri was never just to create products," said Mariah Eckhardt, CEO of Alubri, in the company's launch announcement. "We are responding to a real unmet need in women's health...Alubri brings clinical rigor, medical oversight, and true innovation to a category that has too often been dismissed."

A New Contender in a Booming Market

Alubri steps into a fiercely competitive yet burgeoning landscape. The global women's intimate care market is on a significant growth trajectory, with some projections estimating it will surpass $48 billion by 2036. This growth is fueled by a cultural shift towards destigmatizing women's health issues, a greater emphasis on self-care, and a rising demand for products with transparent, science-backed formulations.

This new venture will compete with established household names like Vagisil and Replens, which have long dominated drugstore shelves. However, its strategy appears more aligned with a newer class of FemTech and wellness brands that prioritize specific life stages and evidence-based solutions. Bonafide Health, for example, has successfully carved out a niche with its focus on non-hormonal, clinically researched menopause relief products. Alubri seems poised to occupy a similar space, blending medical authority with the premium, aesthetically pleasing packaging more commonly associated with the skincare industry.

By emphasizing its foundation in gynecologic care, the brand is making a direct appeal to consumers who are increasingly skeptical of vague wellness claims and are seeking products grounded in tangible science.

The Science Behind the Formulations

Alubri's initial portfolio consists of four core products: a Vaginal Moisturizing Gel ($29.99), Vulva Balm ($24.99), Intimate Serum ($24.99), and a Calming Cream ($29.99). The collection is built around several key ingredients, most notably Sodium Hyaluronate, a derivative of hyaluronic acid renowned for its powerful hydrating properties.

Sodium Hyaluronate is a well-established humectant in both skincare and vaginal health, with clinical studies supporting its efficacy in alleviating vaginal dryness. Its inclusion lends significant scientific credibility to Alubri's moisturizing claims and aligns its products with other premium offerings in the market that also leverage this ingredient. The Vaginal Moisturizing Gel promises up to 72 hours of hydration, aiming to improve tissue elasticity and reduce irritation over time.

Other highlighted ingredients include Allantoin, a compound known for its soothing and skin-protecting properties in dermatological applications, and Dragon Fruit Extract, which is rich in antioxidants. The brand also features a proprietary “Activated Oil Complex,” which it claims helps balance the vaginal microbiome. While the benefits of Allantoin for skin are well-documented, the specific efficacy of Dragon Fruit Extract and the proprietary oil blend for vaginal and vulvar health will rely on the brand's internal research and formulation expertise.

Notably, the Calming Cream is formulated with hydrocortisone, a standard over-the-counter external analgesic used to provide temporary relief from itching and irritation. This positions the product as a direct, symptom-focused solution, similar to anti-itch creams offered by legacy brands but presented within Alubri’s modern, skincare-inspired aesthetic.

"Every Alubri product is developed with careful attention to formulation, ingredient integrity, and the biology of the female body– because women deserve evidence-based solutions that truly serve them," stated co-founder Dr. Nicole Kerner.

Targeting an Underserved Demographic

The brand's most pointed strategic decision is its focus on the perimenopausal and menopausal demographic—a group historically underserved by the mainstream beauty and wellness industries. As estrogen levels decline during this life stage, many women experience vaginal dryness, irritation, and discomfort, which can significantly impact their quality of life. Alubri's messaging directly addresses these challenges, offering solutions designed for confidence and comfort.

"During perimenopause and menopause...vaginal changes are common but meaningful solutions are limited," Eckhardt noted, highlighting the market gap Alubri intends to fill. This focus aligns with a major trend in the broader FemTech market, which has seen explosive growth in services and products dedicated to menopause care, from symptom trackers to non-hormonal therapies.

By having an OB/GYN as a co-founder, the brand aims to build trust with women who may feel dismissed or unheard by the healthcare system when it comes to menopausal symptoms. Dr. Kerner's involvement is central to the brand's identity, framing it as a solution born from clinical experience.

"I wanted to develop Alubri to bring rigor and respect back to women's intimate care by solving the real, unmet needs I see in my patients every day," Dr. Kerner explained. This narrative of a medical professional creating a direct-to-consumer solution is a powerful tool for building credibility in a crowded market.

Balancing Accessibility and a Premium Feel

Alubri is navigating a careful balance with its pricing and positioning. With products ranging from approximately $25 to $30, the line is priced above mass-market drugstore options but remains significantly more accessible than some medically-positioned specialty brands, where a single product can cost upwards of $60. This mid-tier pricing, combined with what the company calls “premium skincare-inspired aesthetics,” suggests a strategy to democratize expert-led intimate care.

The goal appears to be to elevate the user experience, transforming the purchase from a reluctant necessity into a desirable act of self-care. By removing the clinical, often sterile packaging common in the category and replacing it with an aesthetic that wouldn't look out of place next to a luxury face serum, Alubri hopes to remove barriers and encourage more women to prioritize their intimate wellness without shame or stigma. The brand's success will ultimately depend on its ability to deliver on its promise of proven efficacy while fostering the community and open conversation that its “science meets sisterhood” ethos champions.